Oncocytic Carcinoma of the Thyroid

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-02
Clinical Trial Update: Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation [Phase 2]
Phase 2 clinical trial evaluating the combination of vemurafenib and cobimetinib in high-risk differentiated thyroid carcinoma with BRAFV600…